STOCK TITAN
  1. Home
  2. Sec-filings
  3. RVPH
  4. [ARS] REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC Filing

[ARS] REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - REVIVA PHARMACEUTICALS HOLDINGS, INC.

ARS Filing - REVIVA PHARMACEUTICALS HOLDINGS, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Acceptance Date: 2025-11-04T16:21:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock RVPH logo
Reviva Pharmaceutcls Hldgs Inc

NASDAQ:RVPH

RVPH Rankings

#5701 Ranked by Market Cap
N/A Ranked by Dividends

RVPH Latest News

Dec 29, 2025
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
Dec 23, 2025
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
Nov 13, 2025
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Nov 12, 2025
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025
Nov 10, 2025
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

RVPH Latest SEC Filings

Nov 13, 2025
[10-Q] REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Earnings Report
Nov 13, 2025
[8-K] REVIVA PHARMACEUTICALS HOLDINGS, INC. Reports Material Event
Nov 4, 2025
[DEF 14A] REVIVA PHARMACEUTICALS HOLDINGS, INC. Definitive Proxy Statement
Oct 24, 2025
[PRE 14A] REVIVA PHARMACEUTICALS HOLDINGS, INC. Preliminary Proxy Statement
Oct 17, 2025
[8-K] REVIVA PHARMACEUTICALS HOLDINGS, INC. Reports Material Event

RVPH Stock Data

37.75M
111.91M
7.27%
21.07%
19.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
CUPERTINO